Carcinogenesis, Vol 18, 121-125, Copyright © 1997 by Oxford University Press
SP Hussain, CH Kennedy, P Amstad, H Lui, JF Lechner and CC Harris
Radon-222, a decay product of uranium-238 and a source of high linear
energy transfer (LET) alpha-particles, has been implicated in the increased
risk of lung cancer in uranium miners as well as non-miners. p53 mutation
spectrum studies of radon-associated lung cancer have failed to show any
specific mutational hot spot with the exception of a single study in which
31% of squamous cell and large cell lung cancers from uranium miners showed
a p53 codon 249 AGGarg --> ATGmet mutation. Although the results of
laboratory studies indicate that double-strand breaks and deletions are the
principal genetic alterations caused by alpha-particles, uncertainty still
prevails in the description of DNA damage in radon-associated human lung
cancer. In the present study, we have evaluated the mutability of p53
codons 249 and 250 to alpha- particles in normal human bronchial epithelial
(NHBE) cells using a highly sensitive genotypic mutation assay. Exposure of
NHBE cells to a total dose of 4 Gy (equivalent to approximately 1460
working level months in uranium mining) of high LET alpha-radiation induced
codon 249 AGG --> AAG transitions and codon 250 CCC --> ACC
transversions with absolute mutation frequencies of 3.6 x 10(-7) and 3.8 x
10(-7) respectively. This mutation spectrum is consistent with our previous
report of radon-associated human lung cancer.
ARTICLES
Radon and lung carcinogenesis: mutability of p53 codons 249 and 250 to 238Pu alpha-particles in human bronchial epithelial cells
Laboratory of Human Carcinogenesis, NCI, NIH, Bethesda, MD 20892-4255, USA.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
G.J.S. Jenkins, H.S. Suzen, R.A. Sueiro, and J.M. Parry The restriction site mutation assay: a review of the methodology development and the current status of the technique Mutagenesis, September 1, 1999; 14(5): 439 - 448. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Iwamoto, S. Fujii, A. Kurata, M. Suzuki, T. Hayashi, Y. Ohtsuki, Y. Okada, M. Narita, M. Takahashi, S. Hosobe, et al. p53 mutations in tumor and non-tumor tissues of Thorotrast recipients: a model for cellular selection during radiation carcinogenesis in the liver Carcinogenesis, July 1, 1999; 20(7): 1283 - 1291. [Abstract] [Full Text] [PDF] |
||||

